Fujirebio Acquires Plasma Services Group to Bolster Supply of High-Quality Biological Materials for Diagnostics and Life Sciences
HU Group Holdings Inc. and its wholly owned subsidiary Fujirebio Holdings, Inc. (“Fujirebio”) announced today that Fujirebio’s subsidiary, Fujirebio Diagnostics, Inc., has acquired all of the shares of Plasma Services Group, Inc. (“Plasma Services Group”). The transaction amount was not…
Axcelead DDP and Superluminal to Collaborate on Targeted Drug Discovery, Building on Established Partnership
Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) and Superluminal Medicines, Inc. (Superluminal) announced the intention to collaborate on drug discovery targeting specific molecular mechanisms associated with challenging biological targets. The two companies have built a strong relationship through prior collaborations.…
ZEISS Vision Care US Appoints Healthcare Industry Veteran Gary Rosenblum as President and CEO
ZEISS Vision Care US Appoints Healthcare Industry Veteran Gary Rosenblum as President and CEO ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, announced today that Gary Rosenblum has been named President and Chief…
LifePlus Achieves Global Clinical Validation for Innovative Non-Invasive Glucose and Cuffless Blood Pressure Monitoring Platform
LifePlus, a Silicon Valley startup redefining personal health monitoring, today announced the clinical validation of LifeLeaf®, the world’s first non-invasive and cuffless wearable for continuous glucose and blood pressure tracking. The device, tested in global multi-center trials including Mayo Clinic,…
Kopin to Present Advanced Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025
Kopin to Present Advanced Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025 Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced…
NEL Animal Cardiovascular Center Performs World’s First Surgical Correction of Complex VSD in a Canine Patient
NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world’s first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. Although this was…
Intelas Ushers in a New Era for Compass One Healthcare’s Technology Management Transformation
Compass One Healthcare has announced its signature Healthcare Technology Management (HTM) brand: Intelas. Healthcare is evolving rapidly, and the need for integration, standardization, and scale is growing with it. Intelas exemplifies that and represents the next evolution of HTM at Compass…
Hepatoscope® Expands Commercial Reach and Proves Clinical Viability as a Non-Invasive Liver Assessment System
After successfully presenting Hepatoscope at the DDW conference in San Diego and EASL in Amsterdam, French medical ultrasound company E-Scopics is continuing to present its unique liver assessment software system at the June 2025 American Diabetes Association conference in Chicago.…
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
Simulmedia, a national leader in data-driven TV and streaming advertising, today announced a strategic partnership with OptimizeRx Corp. a leading provider of healthcare technology solutions, to enable the self-serve availability of Micro-Neighborhood® Targeting (MNT) audiences across linear, digital, and connected TV (CTV)…
Alcon Launches Clareon PanOptix Pro in Canada: A Breakthrough Trifocal IOL Designed to Minimize Light Scatter
Alcon (SIX/NYSE: ALC), the global eye care leader dedicated to helping people see with clarity, today announced the approval of the Clareon MD PanOptix MD Pro intraocular lens (IOL) for cataract patients in Canada. The PanOptix Pro IOL features ENLIGHTEN MD NXT optics , a proprietary…
Biocytogen Refutes Harbour BioMed’s Patent Claims, Asserts RenNano® Is Independently Developed and Legally Robust
In response to Harbour BioMed’s recent press release regarding a decision in its pending lawsuit, Biocytogen is issuing the following statement: Biocytogen operates in accordance with its core values: independent innovation, respect for intellectual property, and commitment to fair competition . The…
CharmHealth Innovation Challenge Returns with $10K Prize, Showcases Agentic AI in Healthcare
CharmHealth, a leader in healthcare technology solutions for providers, today announced that its 2025 Innovation Challenge continues to accept proposals from innovators, entrepreneurs and developers. The annual competition seeks fresh ideas that drive impact across the healthcare ecosystem. “The Innovation Challenge is…